Inventor · disambiguated record
Daniel Solomon Gold
Also filed as: GOLD DANIEL · GOLD DANIEL SOLOMON
8 granted patents·5 pending applications·66 citations·filing 2010–2025
88Inventor score
Top patents by PatentIndex Score
13 records- 0194US9834587B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 5, 2017·6 cites·12 claims
- 0294US9834588B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 5, 2017·7 cites·12 claims
- 0393US10301369B2Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteinsBIOMARIN PHARM INC·Filed 2017·Granted May 28, 2019·5 cites·17 claims
- 0492US9771408B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Sep 26, 2017·4 cites·12 claims
- 0591US9845346B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2015·Granted Dec 19, 2017·4 cites·12 claims
- 0691US9376480B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2013·Granted Jun 28, 2016·6 cites·21 claims
- 0790US11254725B2Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2019·Granted Feb 22, 2022·2 cites·13 claims
- 0890US8778631B2Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis systemVOLOSHIN ALEXEI M·Filed 2010·Granted Jul 15, 2014·32 cites·31 claims
- 0980US2022127326A1Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses ThereofBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 1077US2025388644A1Targeted therapeutic lysosomal enzyme fusion proteins and uses thereofBIOMARIN PHARM INC·Filed 2025·Application pending·0 cites
- 1155US2023407328A1Process for enriching adeno-associated virusBIOMARIN PHARM INC·Filed 2021·Application pending·0 cites
- 1245US2010184134A1Dual charging system for selectively introducing non-native amino acids into proteins using an in vitro synthesis methodSUTRO BIOPHARMA INC·Filed 2010·Application pending·0 cites
- 1334US2010203587A1Use of dna gyrase inhibitors for in vitro polypeptide synthesis reactionsSUTRO BIOPHARMA INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →